Readers respond to articles and columnists.
eClinical Wish List
The June 2004 article "Meeting the Challenges of Internet-based Clinical Trials" describes the current state of the art of Internet-based clinical trials. Just to ensure that the technologies do not rest on their laurels, the next generation of technology-e-source documents-will truly revolutionize clinical research.
E-source documents will eliminate batch processing of data and almost all manual transcription, the presence of which guarantees an inefficient and error-prone data capture and reporting process.
Here is my wish list for e-source document technology:
While we're at it, it's time to rethink the source document. Using current source documents is like singing a song with the words on one page (the source document) and the notes on another (the protocol). With a combined "scripted source document," we can eliminate a lot of wasted time and errors by integrating step-by-step protocol instructions with data capture fields.
All the technology to implement scripted e-source documents exists today. What are we waiting for?
Norman GoldfarbPresident & CEO
First Clinical Research
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Oveporexton Shows Superior Efficacy in Phase II Narcolepsy Type 1 Trial Without Hepatotoxicity
May 16th 2025In the TAK-861-2001 Phase IIb study, oveporexton significantly improved wakefulness, daytime sleepiness, and cataplexy frequency in patients with narcolepsy type 1, outperforming current therapies and avoiding liver toxicity seen with earlier OX2R agonists, according to results published in The New England Journal of Medicine.